Beta-Hydroxybutyrate - Uses in the ICU
Dr. Mark Oltermann
Thursday, June 12, 2014
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Disclosures/Biases
Mark H Oltermann MD
Diabetic Ketoacidosis (DKA)
DKA-Diabetic Ketoacidosis
Causes of Ketosis
Signs and Symptoms of Diabetic Ketoacidosis
DKA: Diabetic Ketoacidosis
DKA Diagnostic Criteria
Management of DKA
Management of DKA pt 2
DKA Labs
Why Measure β-HB?
Acid-Base Chemistry
To Summarize
Accuracy with Monitoring
Impact of β-HB
Conclusion
No transcript for this webinar
Request info